Ascendis Pharma Financials
| A1SN34 Stock | BRL 56.10 0.00 0.00% |
Ascendis |
Understanding current and past Ascendis Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ascendis Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Ascendis Pharma's assets may result in an increase in income on the income statement.
Please note, the presentation of Ascendis Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ascendis Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ascendis Pharma's management manipulating its earnings.
| Instrument | Brazil Stock View All |
| Exchange | Sao Paulo Exchange |
| Business Address | Tuborg Boulevard 12, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | ascendispharma.com |
| Phone | 45 70 22 22 44 |
| Currency | BRL - Brazilian Real |
You should never invest in Ascendis Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Ascendis Stock, because this is throwing your money away. Analyzing the key information contained in Ascendis Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Ascendis Pharma Key Financial Ratios
Ascendis Pharma's financial ratios allow both analysts and investors to convert raw data from Ascendis Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of Ascendis Pharma over time and compare it to other companies across industries.Ascendis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ascendis Pharma's current stock value. Our valuation model uses many indicators to compare Ascendis Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ascendis Pharma competition to find correlations between indicators driving Ascendis Pharma's intrinsic value. More Info.Ascendis Pharma AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Ascendis Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ascendis Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Ascendis Pharma AS Systematic Risk
Ascendis Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ascendis Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Ascendis Pharma AS correlated with the market. If Beta is less than 0 Ascendis Pharma generally moves in the opposite direction as compared to the market. If Ascendis Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ascendis Pharma AS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ascendis Pharma is generally in the same direction as the market. If Beta > 1 Ascendis Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Ascendis Pharma March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ascendis Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ascendis Pharma AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ascendis Pharma AS based on widely used predictive technical indicators. In general, we focus on analyzing Ascendis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ascendis Pharma's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1386 | |||
| Maximum Drawdown | 10.51 |
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |